Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

May 01, 1983; Volume 23,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Allen, D L

    1. You have access
      A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;

B

  1. Ballot, B A

    1. You have access
      Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;
  2. Barnes, P J

    1. You have access
      Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;
  3. Benga, G

    1. You have access
      Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;
  4. Bessler, W G

    1. You have access
      Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;
  5. Birdsall, N J

    1. You have access
      Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;
  6. Black, K A

    1. You have access
      Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
      K A Black and T R Tephly
      Molecular Pharmacology May 1983, 23 (3) 724-730;
  7. Bockaert, J

    1. You have access
      Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
      A Enjalbert and J Bockaert
      Molecular Pharmacology May 1983, 23 (3) 576-584;
  8. Burgen, A S

    1. You have access
      Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;

C

  1. Chang, H

    1. You have access
      Identification of 2-imidazolines as anti-sickling agents.
      H Chang, S M Ewert and R L Nagel
      Molecular Pharmacology May 1983, 23 (3) 731-734;
  2. Chemnitius, J M

    1. You have access
      Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
      J M Chemnitius and R Zech
      Molecular Pharmacology May 1983, 23 (3) 717-723;
  3. Combest, W L

    1. You have access
      Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
      W L Combest and D H Russell
      Molecular Pharmacology May 1983, 23 (3) 641-647;
  4. Craviso, G L

    1. You have access
      High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 619-628;
    2. You have access
      High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 629-640;
  5. Creese, I

    1. You have access
      Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
      D R Sibley and I Creese
      Molecular Pharmacology May 1983, 23 (3) 585-593;

D

  1. Douglas, K T

    1. You have access
      Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;
  2. Dumbrille-Ross, A

    1. You have access
      Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
      A Dumbrille-Ross and S W Tang
      Molecular Pharmacology May 1983, 23 (3) 607-613;
  3. Dwyer, L A

    1. You have access
      Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;

E

  1. Edwards, M C

    1. You have access
      Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;
  2. Eling, T E

    1. You have access
      An electron spin resonance study of the activation of benzidine by peroxidases.
      P D Josephy, T E Eling and R P Mason
      Molecular Pharmacology May 1983, 23 (3) 766-770;
  3. Enjalbert, A

    1. You have access
      Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
      A Enjalbert and J Bockaert
      Molecular Pharmacology May 1983, 23 (3) 576-584;
  4. Enna, S J

    1. You have access
      [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
      D A Kendall, D P Taylor and S J Enna
      Molecular Pharmacology May 1983, 23 (3) 594-599;
  5. Evans, F J

    1. You have access
      Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;
  6. Ewert, S M

    1. You have access
      Identification of 2-imidazolines as anti-sickling agents.
      H Chang, S M Ewert and R L Nagel
      Molecular Pharmacology May 1983, 23 (3) 731-734;

F

  1. Fischer, P H

    1. You have access
      Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
      P H Fischer, M A Weddle and R D Mossie
      Molecular Pharmacology May 1983, 23 (3) 709-716;
  2. Frye, R A

    1. You have access
      Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
      R A Frye and R W Holz
      Molecular Pharmacology May 1983, 23 (3) 547-550;

G

  1. Gordon, D

    1. You have access
      Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;
  2. Grove, J R

    1. You have access
      Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
      J L Vannice, J R Grove and G M Ringold
      Molecular Pharmacology May 1983, 23 (3) 779-785;

H

  1. Hennings, G

    1. You have access
      Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;
  2. Hider, R C

    1. You have access
      Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;
  3. Hollenberg, P F

    1. You have access
      Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;
  4. Holz, R W

    1. You have access
      Phospholipase A2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells.
      R A Frye and R W Holz
      Molecular Pharmacology May 1983, 23 (3) 547-550;
  5. Hulme, E C

    1. You have access
      Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;
  6. Hyman, A L

    1. You have access
      Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

I

  1. Ignarro, L J

    1. You have access
      Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;
  2. Ionescu, M

    1. You have access
      Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;

J

  1. Jakoby, W B

    1. You have access
      Cysteine conjugate beta-lyase.
      J Stevens and W B Jakoby
      Molecular Pharmacology May 1983, 23 (3) 761-765;
  2. Javitch, J A

    1. You have access
      3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
      C M Lee, J A Javitch and S H Snyder
      Molecular Pharmacology May 1983, 23 (3) 563-569;
  3. Jaworski, C J

    1. You have access
      Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts.
      G S Johnson and C J Jaworski
      Molecular Pharmacology May 1983, 23 (3) 648-652;
  4. Jefcoate, C R

    1. You have access
      Modulation of microsomal benzo[a]pyrene metabolism by DNA.
      G M Keller and C R Jefcoate
      Molecular Pharmacology May 1983, 23 (3) 735-742;
  5. Jeffery, E H

    1. You have access
      Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
      E H Jeffery and G J Mannering
      Molecular Pharmacology May 1983, 23 (3) 748-757;
  6. Johnson, G S

    1. You have access
      Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts.
      G S Johnson and C J Jaworski
      Molecular Pharmacology May 1983, 23 (3) 648-652;
  7. Josephy, P D

    1. You have access
      An electron spin resonance study of the activation of benzidine by peroxidases.
      P D Josephy, T E Eling and R P Mason
      Molecular Pharmacology May 1983, 23 (3) 766-770;
  8. Jung, G

    1. You have access
      Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;

K

  1. Kadowitz, P J

    1. You have access
      Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;
  2. Kedderis, G L

    1. You have access
      Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;
  3. Keller, G M

    1. You have access
      Modulation of microsomal benzo[a]pyrene metabolism by DNA.
      G M Keller and C R Jefcoate
      Molecular Pharmacology May 1983, 23 (3) 735-742;
  4. Kendall, D A

    1. You have access
      [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
      D A Kendall, D P Taylor and S J Enna
      Molecular Pharmacology May 1983, 23 (3) 594-599;

L

  1. Lajtha, A

    1. You have access
      A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;
  2. Lambeth, J D

    1. You have access
      22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol.
      J D Lambeth
      Molecular Pharmacology May 1983, 23 (3) 743-747;
  3. Lee, C M

    1. You have access
      3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
      C M Lee, J A Javitch and S H Snyder
      Molecular Pharmacology May 1983, 23 (3) 563-569;
  4. Lin, C W

    1. You have access
      The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
      C W Lin and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 558-562;

M

  1. Mannering, G J

    1. You have access
      Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
      E H Jeffery and G J Mannering
      Molecular Pharmacology May 1983, 23 (3) 748-757;
  2. Mason, R P

    1. You have access
      An electron spin resonance study of the activation of benzidine by peroxidases.
      P D Josephy, T E Eling and R P Mason
      Molecular Pharmacology May 1983, 23 (3) 766-770;
  3. Mellion, B T

    1. You have access
      Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;
  4. Mossie, R D

    1. You have access
      Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
      P H Fischer, M A Weddle and R D Mossie
      Molecular Pharmacology May 1983, 23 (3) 709-716;
  5. Musacchio, J M

    1. You have access
      The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures.
      C W Lin and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 558-562;
    2. You have access
      High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 619-628;
    3. You have access
      High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments.
      G L Craviso and J M Musacchio
      Molecular Pharmacology May 1983, 23 (3) 629-640;
  6. Myers, C B

    1. You have access
      Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

N

  1. Nadel, J A

    1. You have access
      Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;
  2. Nagel, R L

    1. You have access
      Identification of 2-imidazolines as anti-sickling agents.
      H Chang, S M Ewert and R L Nagel
      Molecular Pharmacology May 1983, 23 (3) 731-734;
  3. Nouri, A M

    1. You have access
      Tumor-promoting and nonpromoting proinflammatory esters act as human lymphocyte mitogens with different sensitivities to inhibition by cyclosporin A.
      M C Edwards, A M Nouri, D Gordon and F J Evans
      Molecular Pharmacology May 1983, 23 (3) 703-708;

O

  1. Ohlstein, E H

    1. You have access
      Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
      B T Mellion, L J Ignarro, C B Myers, E H Ohlstein, B A Ballot, A L Hyman and P J Kadowitz
      Molecular Pharmacology May 1983, 23 (3) 653-664;

P

  1. Pfeifer, M

    1. You have access
      Interaction of metal-complexing compounds with lymphocytes and lymphoid cell lines.
      G Jung, G Hennings, M Pfeifer and W G Bessler
      Molecular Pharmacology May 1983, 23 (3) 698-702;
  2. Pocock, G

    1. You have access
      Ionic and metabolic requirements for stimulation of secretion by ouabain in bovine adrenal medullary cells.
      G Pocock
      Molecular Pharmacology May 1983, 23 (3) 671-680;
    2. You have access
      Ion movements in isolated bovine adrenal medullary cells treated with ouabain.
      G Pocock
      Molecular Pharmacology May 1983, 23 (3) 681-697;
  3. Pop, V I

    1. You have access
      Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;
  4. Popescu, O

    1. You have access
      Effect of chlorpromazine on proteins in human erythrocyte membranes as inferred from spin labeling and biochemical analyses.
      G Benga, M Ionescu, O Popescu and V I Pop
      Molecular Pharmacology May 1983, 23 (3) 771-778;

R

  1. Reith, M E

    1. You have access
      A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;
  2. Rickert, D E

    1. You have access
      Source of the oxygen atom in the product of cytochrome P-450-catalyzed N-demethylation reactions.
      G L Kedderis, L A Dwyer, D E Rickert and P F Hollenberg
      Molecular Pharmacology May 1983, 23 (3) 758-760;
  3. Ringold, G M

    1. You have access
      Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
      J L Vannice, J R Grove and G M Ringold
      Molecular Pharmacology May 1983, 23 (3) 779-785;
  4. Roberts, J M

    1. You have access
      Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;
  5. Russell, D H

    1. You have access
      Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
      W L Combest and D H Russell
      Molecular Pharmacology May 1983, 23 (3) 641-647;

S

  1. Sershen, H

    1. You have access
      A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
      M E Reith, H Sershen, D L Allen and A Lajtha
      Molecular Pharmacology May 1983, 23 (3) 600-606;
  2. Sharma, R K

    1. You have access
      Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;
  3. Sibley, D R

    1. You have access
      Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
      D R Sibley and I Creese
      Molecular Pharmacology May 1983, 23 (3) 585-593;
  4. Silver, P J

    1. You have access
      Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
      P J Silver and J T Stull
      Molecular Pharmacology May 1983, 23 (3) 665-670;
  5. Skoogh, B E

    1. You have access
      Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
      P J Barnes, B E Skoogh, J A Nadel and J M Roberts
      Molecular Pharmacology May 1983, 23 (3) 570-575;
  6. Snyder, S H

    1. You have access
      3h-substance P binding to salivary gland membranes. Regulation by guanyl nucleotides and divalent cations.
      C M Lee, J A Javitch and S H Snyder
      Molecular Pharmacology May 1983, 23 (3) 563-569;
  7. Stevens, J

    1. You have access
      Cysteine conjugate beta-lyase.
      J Stevens and W B Jakoby
      Molecular Pharmacology May 1983, 23 (3) 761-765;
  8. Stockton, J M

    1. You have access
      Modification of the binding properties of muscarinic receptors by gallamine.
      J M Stockton, N J Birdsall, A S Burgen and E C Hulme
      Molecular Pharmacology May 1983, 23 (3) 551-557;
  9. Stull, J T

    1. You have access
      Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
      P J Silver and J T Stull
      Molecular Pharmacology May 1983, 23 (3) 665-670;

T

  1. Tang, S W

    1. You have access
      Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
      A Dumbrille-Ross and S W Tang
      Molecular Pharmacology May 1983, 23 (3) 607-613;
  2. Taylor, D P

    1. You have access
      [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
      D A Kendall, D P Taylor and S J Enna
      Molecular Pharmacology May 1983, 23 (3) 594-599;
  3. Tephly, T R

    1. You have access
      Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
      K A Black and T R Tephly
      Molecular Pharmacology May 1983, 23 (3) 724-730;

V

  1. Vannice, J L

    1. You have access
      Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells.
      J L Vannice, J R Grove and G M Ringold
      Molecular Pharmacology May 1983, 23 (3) 779-785;

W

  1. Walmsley, J F

    1. You have access
      Ionization processes of some harmala alkaloids.
      K T Douglas, R K Sharma, J F Walmsley and R C Hider
      Molecular Pharmacology May 1983, 23 (3) 614-618;
  2. Weddle, M A

    1. You have access
      Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
      P H Fischer, M A Weddle and R D Mossie
      Molecular Pharmacology May 1983, 23 (3) 709-716;

Z

  1. Zech, R

    1. You have access
      Inhibition of brain carboxylesterases by neurotoxic and nonneurotoxic organophosphorus compounds.
      J M Chemnitius and R Zech
      Molecular Pharmacology May 1983, 23 (3) 717-723;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 23, Issue 3
1 May 1983
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics